Atreca
Atreca, based in San Carlos, CA, develops novel therapeutics focused on the human immune response, particularly in oncology, using its proprietary Atreca Discovery Platform.
Company Location
Atreca is located in San Carlos, California, United States. The company is situated in a region known for its significant concentration of biotechnology and pharmaceutical firms. Its location in the heart of Silicon Valley positions it strategically within an ecosystem of innovation and advanced research.
Novel Therapeutics Development
Atreca develops novel therapeutics grounded in a profound understanding of human immune responses. The company focuses on exploiting the immune responses of patients, particularly in therapeutic areas where these responses are critical to clinical outcomes. This approach underpins their commitment to advancing treatments that harness the body's natural defenses.
Atreca Discovery Platform
The proprietary Atreca Discovery Platform is a cornerstone of the company's research and development efforts. This platform is central to discovering new immunotherapies by offering unprecedented insights into the human immune response. It has been validated through collaborations with major pharmaceutical companies, non-profit foundations, academic institutions, and governmental entities.
Oncology Therapeutics Pipeline
Atreca is developing a pipeline of antibody-based oncology therapeutics. These therapeutics are designed to target key phenomena in immuno-oncology, aiming to harness the body's immune system to fight cancer. The focus is on creating treatments that offer new possibilities for patients with various forms of cancer.
Partnerships and Collaborations
Atreca's Discovery Platform has been successfully validated through its various partnerships. These include collaborations with major pharmaceutical companies, non-profit foundations, academic institutions, and governmental entities. Such alliances are crucial for advancing the company's research and expanding the impact of its innovative therapeutic solutions.